Plain-language summary
A modern mechanistic review focused on carnosine's antioxidant chemistry and how that chemistry maps onto neurodegenerative disease — Alzheimer's, Parkinson's, ALS, and Huntington's. The authors organize the evidence around the shared upstream driver of oxidative stress, then weigh translational readiness disease by disease.
Key takeaways
- ›Aligns antioxidant mechanism with specific neurodegenerative pathologies.
- ›Translational readiness varies sharply across diseases — useful framing.
- ›Up-to-date complement to the older Boldyrev neuroprotection literature.
About this summary
The summary and key takeaways above are written by our editorial team in plain language for general readers. They are not the original abstract. For the authors' own wording, methodology, statistics, and full reference list, follow the source link to the published record.